Italy’s Draft WHO resolution: Improving the transparency of markets for drugs, vaccines and other health-related technologies

On February 1, 2019, the Minister of Health in Italy Dr. Giulia Grillo sent a letter to Dr. Tedros Adhanom Ghebreyesus, the Director General of the World Health Organization (WHO), with an attached “first draft” of a resolution on “Improving… Continue Reading

EB144: KEI statement on the WHO roadmap on access to medicines, vaccines and health products

Knowledge Ecology International (KEI) delivered the following statement on the WHO roadmap on access to medicines, vaccines and health products (agenda item 5.7.1) on Tuesday evening, 29 January 2019 during the 144th session of WHO’s Executive Board. The WHO Roadmap… Continue Reading

EB144: KEI statement on Preparation for the high-level meeting of the General Assembly on universal health coverage

Knowledge Ecology International (KEI) will make the following intervention on agenda item 5.5.3 titled “Preparation for the high-level meeting of the General Assembly on universal health coverage.” Currently, WHO member states are involved in intense negotiations on a draft resolution… Continue Reading

WHO Cancer Report – Key findings

On 18 December 2018, the World Health Organization (WHO) published a “Technical report on Pricing of cancer medicines and its impacts” (hereinafter referred to as the “WHO Cancer Report”). The mandate for the WHO Cancer Report emanates from operative paragraph… Continue Reading

KEI Intent to Testify and Testimony Summary/Comments on Negotiating Objectives for a U.S.-European Union Trade Agreement (USEUTA)

DATE: December 10, 2018 Intent to Testify and Testimony Summary/Comments on Negotiating Objectives for a U.S.-European Union Trade Agreement (USEUTA) Luis Gil Abinader. Knowledge Ecology International 1621 Connecticut Avenue, Northwest, Suite 500, Washington, DC 20009. Phone number +1.202.332.2670. Federal Register… Continue Reading

Pfizer asked USTR to block Malaysia requirement on drug price transparency. September 2017

KEI has received Pfizer and USTR emails and a Pfizer briefing memo to USTR from September 2017, asking the USTR to block a Malaysia Requirement to disclose drug prices. The documents were obtained under a Freedom of Information request to… Continue Reading